Drug-Induced Lung Injury

Häftad, Engelska, 2019

Del i serien Respiratory Disease Series: Diagnostic Tools and Disease Managements

1 094 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

Beskrivning

This book covers various aspects of a respiratory system disorder associated with prescribed drugs that do not yet have established treatment guidelines, and for which the only treatment is to discontinue taking the drug.

Produktinformation

Utgivningsdatum:2019-01-08
Mått:155 x 235 x 12 mm
Vikt:394 g
Format:Häftad
Språk:Engelska
Serie:Respiratory Disease Series: Diagnostic Tools and Disease Managements
Antal sidor:215
Förlag:Springer Verlag, Singapore
ISBN:9789811351464

Utforska kategorier

Lungmedicin inom Medicin

Mer om författaren

EditorsMasayuki HanaokaFirst Department of MedicineShinshu University School of MedicineMatsumoto, JapanHiroyuki NakamuraDepartment of Respiratory MedicineTokyo Medical University Ibaraki Medical CenterIbaraki, JapanKazutetsu AoshibaDepartment of Respiratory MedicineTokyo Medical University Ibaraki Medical CenterIbaraki, Japan

Innehållsförteckning

Part I　Definition, Pathogenesis, and Epidemiology.- 1. Definition, Pathogenesis and Epidemiology: What is DLI?.- 2. Epidemiology and Risk Factors of Drug-Induced Lung Disease: What are the prevalence and risk factors of DLI?.- 3. Clinical Characteristics of DLI: What are the clinical features of DLI?.- Part II　Diagnosis.- 4. Diagnostic Approach for DLI: How is DLI diagnosed?.- 5. Blood tests for the diagnosis and/or management of DLI: What are the clinical significances of KL-6, SP-A, SP-D and DLST in DLI?.- 6. Imaging features of drug-induced interstitial lung disease: How HRCT of DLI is interpreted?.- 7. Pathology of DLI: What is the pathological significance of DLI?.- 8. Differential Diagnosis of DLI: What are the differential diagnoses of DLI?.- Part II　Treatment.- 9. Therapeutic Strategies for DLI: How should DLI be treated?.- Part IV　Drugs Causing DLI.- 10. DLI induced by non-molecular target antineoplastic drugs: What are the characteristics of DLI in non-molecular target antineoplastic drugs?.- 11. DLI induced by Molecular Target Antineoplastic Drug: What are the characteristics of DLI in molecular target antineo-plastic drugs?.- 12. DLI caused by disease-modifying antirheumatic drugs: What are the characteristics of DLI by disease-modifying antirheumatic drugs?.- 13. DLI Induced by Herbal Medicine: What are the characteristics of DLI due to herbal medicines?.- 14. DLI induced by Antiarrhythmic Drug and Antimicrobial Drug: What are the characteristics of DLI in antiarrhythmic drugs and antimicrobial drugs?.